Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?

Atherosclerosis is the leading cause of death and morbidity in developed countries and is the culprit behind coronary artery disease , cerebral vascular disease and peripheral artery occlusive disease .

http://www.nature.com/leu/journal/vaop/ncurrent/full/leu2013112a.html